Candela is Recipient of 2004 Frost & Sullivan Product Quality Leadership Award.

Business Editors/Health/Medical Writers

WAYLAND, Mass.--(BUSINESS WIRE)--March 15, 2004

Candela Corporation (NASDAQ: CLZR) announced today that it has been awarded the Frost & Sullivan Product Quality Leadership Award for the United States medical laser markets. This award was given for "Candela's GentleLASE(R) family of products, which offers fast treatment times, high efficacy, and great flexibility for hair removal, wrinkles, pigmented lesions and vascular lesions. The GentleLASE family has found wide-spread acceptance and is the laser of choice."

Gerard E. Puorro, Candela's President and Chief Executive Officer, commented: "We welcome this award from Frost & Sullivan in recognition of our GentleLASE product family as lasers of choice, providing the best in efficacy and economics across various applications. We will continue to listen to our customers and fill their needs."

About Candela:

Candela Corporation develops, manufactures, and distributes innovative clinical solutions that enable physicians, surgeons, and personal care practitioners to treat selected cosmetic and medical conditions using lasers, aesthetic laser systems, and other advanced technologies. Founded near Boston in 1970, the company markets and services its products in over 60 countries from offices in the United States, Europe, Japan and other Asian locations. Candela established the aesthetic laser market 15 years ago, and currently has an installed base of over 7,000 lasers worldwide. Candela is an Equal Opportunity and Affirmative Action Employer (Male/Female/Handicapped/Veteran). Visit Candela on the Web at http://www.candelalaser.com.

Safe Harbor Statement: Except for the historical information contained herein, this news release contains forward-looking statements that constitute Candela's current intentions, hopes, beliefs, expectations or predictions of the future, which are therefore inherently subject to risks and uncertainties. Such statements may relate to, among other things, our growth prospects, market acceptance of our products, the strength of our distribution channels, our ability to add new products, our ability to expand regulatory approvals and the liquidity of our common stock. The risks and uncertainties that may affect forward-looking statements include, among others: the cancellation or deferral of customer orders, dependence on a small number of strategic distribution relationships, difficulties in the timely development and market acceptance of new products, market developments that vary from the current public expectations concerning the growth of the laser industry, increased competitive pressures, changes in economic conditions, or difficulties in obtaining timely regulatory approvals. Further information on factors that could affect Candela's performance is included in Candela's periodic reports filed with the SEC, including but not limited to, Candela's Annual Report on Form 10-K for the year ended June 28, 2003 and subsequent Quarterly Reports on Form 10-Q. Candela cautions readers not to place undue reliance upon any such forward-looking statements, which speak only as of the date made. Candela expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any such statements to reflect any change in Candela's expectations or any change in events, conditions or circumstances on which any such statement is based.